Vol. 47 | No. 1 | January-June 2019Back

Open Access

Continuous-Flow Left Ventricular Assist Device (LVAD) Implantation as Destination Therapy in a Patient with End-Stage Heart Failure Complicated with Cardiorenal Syndrome

More Info

Jastin Gilbert G. Manaloto MD1 | Fe-Aileen F. Arellano-Simon MD1 | Donald C. Cristobal MD1 | Jorge M. Garcia MD2 

1Heart Institute, St. Luke’s Medical Center – Global City  

2Thoracic and Cardiovascular Surgery Department, St. Luke’s Medical Center – Global City

  1. Lam C. Heart failure in Southeast Asia: facts and numbers. ESC Heart Fail. 2015;2(2):46-9.
  2. Tumanan-Mendoza B, et al. Epidemiologic burden of hospitalization for congestive heart failure among adults aged > 19 years in the Philippines. Heart Asia. 2017;9(1):76-80.
  3. Friedrich EB, Böhm M. Management of end stage heart failure. Heart. 2007; 93(5):626-31.
  4. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129-200.
  5. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of left ventricular assist device for end-stage heart failure. N Eng J Med. 2001;345(20):1435-43.
  6. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241-51.
  7. Ross DW, Stevens GR, Wanchoo R, Majure DT, Jauhar S, Fernandez HA, Merzkani M, Jhaveri KD. Left Ventricular Assist Devices and the Kidney. Clin J Am Soc Nephrol 2018 Feb 7; 13(2): 348–355.
  8. Rosner MH, Rastogi A, Ronco C. The cardiorenal syndrome. Int J Nephrol 2011: 982092.
  9. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995;92[Suppl]: II191–II195.
  10. Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, Clelland C, Nojiri C. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg 2002;74:1080–1085.
  11. Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, Toda K, Kawano Y, Nakatani T. Effect of pulsatile left ventricular assist system implantation on Doppler measurements of renal hemodynamics in patients with advanced heart failure. Artif Organs 2012;36:353–358.
  12. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouad-Tarazi FM. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996;93: 1515–1519.
  13. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Givertz MM, Young JB. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant 2013 Dec;32(12):1205-13.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.